Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02991534 · ClinicalTrials.gov registry record · NA
Cardiovascular Risk Screening and Risk Reduction in Women Vets
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 6,009
- Enrollment target
NCT02991534: Completed NA study, sponsored by VA Office of Research and Development.
NCT02991534 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 6,009 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02991534, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,009 participants
- Enrollment target
Study Summary
Cardiovascular (CV) disease is the number one cause of death in American women, and all adult women are potentially at risk for CV disease. There are clear gender differences in the control of CV risk factors such as lipids, blood pressure, and intermediate diabetes outcomes nationally and within the VA, with women Veterans often at higher CV risk than their male counterparts. The combination of disparities and gender-specific CV risk factors suggest an urgent need for CV risk factor management in women Veterans. As one project in the Enhancing Mental and Physical health of Women through Engagement and Retention (EMPOWER) QUERI, the objectives of "Facilitating Cardiovascular Risk Screening and Risk Reduction in Women Veterans" are to implement and evaluate a CV risk reduction toolkit (CV toolkit) designed to increase identification of CV risk among Women Veterans, enhance patient/provider communication about their risk, and increase Women Veterans' engagement and retention in relevant health services including referrals to key health programs (e.g., MOVE!, dieticians, health coaches, and CV specialists as needed). The initial CV Toolkit includes four components: (1) Patient education/activation tools including educational materials and a patient CV self-screener to help make CV risk discussion a priority for women before they enter the exam room; (2) A CV risk assessment computerized template to systematically capture CV disease risk factor history and data from the medical record and then facilitate referrals to Gateway to Healthy Living program and other CV risk reduction services/programs; (3) Provider information and education programs as well as referral tools to internal services; and (4) The Gateway to Healthy Living, a facilitated goal-setting group tailored for women Veterans. The goal is to implement the CV Toolkit at four VA facilities with comprehensive women's health clinics. The implementation of the CV Toolkit will be evaluated using a non-randomized
Interventions
- BEHAVIORAL CV Toolkit Components
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,009 participants |
| Start Date | 2016-11-15 |
| Est. Completion | 2020-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02991534
The ClinicalTrials.gov registry entry for NCT02991534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,009 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CV Toolkit Components is the first listed.
NCT02991534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02991534 about?
NCT02991534 is a clinical study titled "Cardiovascular Risk Screening and Risk Reduction in Women Vets". Cardiovascular (CV) disease is the number one cause of death in American women, and all adult women are potentially at risk for CV disease. There are clear gender differences in the control of CV risk factors such as lipids, blood pressure, and intermediate diabetes outcomes nationally and within th...
What is the current status of trial NCT02991534?
This trial is currently completed. It is a NA study. The enrollment target is 6,009 participants. The study started on 2016-11-15. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT02991534?
The interventions under investigation include: CV Toolkit Components (BEHAVIORAL).
Who is sponsoring clinical trial NCT02991534?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.